Aysenur Yegin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Aysenur Yegin has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Esin Eren
4 shared publications- Necat Yilmaz
ANTALYA EĞİTİM VE ARAŞTIRMA HASTANESİ, TIBBİ BİYOKİMYA
4 shared publications Emirhan Yardan
2 shared publicationsNevin Simsek
2 shared publicationsSadik Buyukbas
2 shared publicationsSakir Aslan
2 shared publications
Latest Publications
- 1 January 2016
- Published by LookUs Bilisim A.S. in Turkish Bulletin of Hygiene and Experimental Biology
- Vol. 73 (3) , 245-252
Comparison of the BioRad D-10TM and Tosoh HLC 723 G8 HPLC instruments for the detection of HbA2
- 1 January 2016
- Published by LookUs Bilisim A.S. in Turkish Bulletin of Hygiene and Experimental Biology
- Vol. 73 (3) , 245-252
Comparison of the BioRad D-10TM and Tosoh HLC 723 G8 HPLC instruments for the detection of HbA2
- 1 January 2015
- Vol. 61 (7) , 769-75
The Diagnostic Value of Oxidative/Antioxidative Balance Parameters in Venous Thromboembolism.
The aim of this study is to observe the association between venous thromboembolism (VTE) and oxidative stress and to see if there is a diagnostic value in the oxidative/antioxidative balance parameters like total oxidant status (TOS), total antioxidant status (TAS), paraoxonase-(PON1), and arylesterase (ARE) enzyme activities in this specific disease. Sixty-nine patients with deep vein thrombosis and/or pulmonary embolism and 40 control subjects were included in the study. Oxidative stress index, total oxidant status, and antioxidant status were examined in addition to the PON1 and ARE enzyme activities in both groups. Serum PON1 and ARE activities were significantly lower in the VTE patients, whereas total oxidant status was higher in patients compared to the controls. This preliminary study showed that oxidative/antioxidative balance shifted towards the oxidative status in venous thromboembolism. ROC analysis results suggested that the parameters used in this study were not good enough to be used in the diagnosis of VTE.
- 1 January 2015
- Vol. 61 (7) , 769-75
The Diagnostic Value of Oxidative/Antioxidative Balance Parameters in Venous Thromboembolism.
The aim of this study is to observe the association between venous thromboembolism (VTE) and oxidative stress and to see if there is a diagnostic value in the oxidative/antioxidative balance parameters like total oxidant status (TOS), total antioxidant status (TAS), paraoxonase-(PON1), and arylesterase (ARE) enzyme activities in this specific disease. Sixty-nine patients with deep vein thrombosis and/or pulmonary embolism and 40 control subjects were included in the study. Oxidative stress index, total oxidant status, and antioxidant status were examined in addition to the PON1 and ARE enzyme activities in both groups. Serum PON1 and ARE activities were significantly lower in the VTE patients, whereas total oxidant status was higher in patients compared to the controls. This preliminary study showed that oxidative/antioxidative balance shifted towards the oxidative status in venous thromboembolism. ROC analysis results suggested that the parameters used in this study were not good enough to be used in the diagnosis of VTE.
- 1 January 2013
- Published by Clinical Laboratory Publications in Clinical Laboratory
- Vol. 59 (05+06/2013)
Decreased Paraoxonase 1, Arylesterase Enzyme Activity, and Enhanced Oxidative Stress in Patients with Mitral and Aortic Valve Insufficiency
- 1 January 2013
- Published by Clinical Laboratory Publications in Clinical Laboratory
- Vol. 59 (05+06/2013)
Decreased Paraoxonase 1, Arylesterase Enzyme Activity, and Enhanced Oxidative Stress in Patients with Mitral and Aortic Valve Insufficiency
- 1 January 2010
- Vol. 56, 513-8
Serum total homocystein, folate and vitamin B12 levels and their correlation with antipsychotic drug doses in adult male patients with chronic schizophrenia.
Elevated blood levels of homocysteine (hCY) have been associated with schizophrenic male patients. However, controversy remains regarding the association between lowered plasma folate and vitamin B12, hyperhomocysteinemia, and schizophrenia. Sixty-six (66) male patients with chronic schizophrenia were investigated to test the hypotheses that alterations in Hcy, folate, and vitamin B12 levels might be related to the antipsychotic drug doses used in treatment. Serum total homocysteine, folic acid, and vitamin B12 levels were determined by chemiluminescence methods in both patients and control subjects. The patients were grouped according to the antipsychotic drug doses used in their treatment. Patients had higher homocysteine levels but they did not differ from controls in terms of folate and vitamin B12 levels. On the other hand, only folate levels were negatively correlated in the patient group treated with higher therapeutic doses of chlorpromazine equivalents (> 400 mg/day) compared to the patient group with lower doses (< 400 mg/day). Our findings show that higher typical antipsychotic drugs may play a role as modifiying factor for folate metabolism in chronic schizoprenic male patients.
- 1 January 2010
- Vol. 56, 513-8
Serum total homocystein, folate and vitamin B12 levels and their correlation with antipsychotic drug doses in adult male patients with chronic schizophrenia.
Elevated blood levels of homocysteine (hCY) have been associated with schizophrenic male patients. However, controversy remains regarding the association between lowered plasma folate and vitamin B12, hyperhomocysteinemia, and schizophrenia. Sixty-six (66) male patients with chronic schizophrenia were investigated to test the hypotheses that alterations in Hcy, folate, and vitamin B12 levels might be related to the antipsychotic drug doses used in treatment. Serum total homocysteine, folic acid, and vitamin B12 levels were determined by chemiluminescence methods in both patients and control subjects. The patients were grouped according to the antipsychotic drug doses used in their treatment. Patients had higher homocysteine levels but they did not differ from controls in terms of folate and vitamin B12 levels. On the other hand, only folate levels were negatively correlated in the patient group treated with higher therapeutic doses of chlorpromazine equivalents (> 400 mg/day) compared to the patient group with lower doses (< 400 mg/day). Our findings show that higher typical antipsychotic drugs may play a role as modifiying factor for folate metabolism in chronic schizoprenic male patients.